Clinical Trial Update: PSMA-PET to Guide Prostatectomy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates a Phase 2/Phase 3 study using PSMA-PET imaging to guide prostatectomy in prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Five Eleven Pharma, Inc. | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: RECRUITING